1. Home
  2. Institute
  3. Who we are
  4. Dr. Jasmina Kirchhoff
Jasmina Kirchhoff

Dr. Jasmina Kirchhoff

Project Manager for Pharmaceutical Location Germany

Tel: +49 221 4981-813
  • Studies in economics at the University of Bielefeld
  • PhD on National Innovation Systems in Transition Countries at Bielefeld University, research stay at the Centre for Innovation, Research and Competence in the Learning Economy (CIRCLE) at Lund University, Sweden
  • Since 2009 at the IW in the competence area Public Finance, Social Security, Distribution
  • until January 2021 Senior Economist at the Research Unit Pharmaceutical Location Germany and Health Care Economy,
  • since February 2021 Project Manager at the Research Unit "Pharmaceuticals in Germany

IW Publications

Kirchhoff, Jasmina, 2021, Mehr Arzneimittel „made in Germany“ über internationale Vernetzung. Industriepolitische Handlungsempfehlungen für eine zukunftsfähige Pharmaindustrie, IW-Policy Paper, Nr. 22, Köln
Zur Studie

Pharmaausfuhren trotzen den globalen Unsicherheiten
IW-Kurzbericht 26/2019

Deutschlands Pharmaindustrie 2017/2018 – Turbulentes Jahr 2017, gedämpfte Aussichten für 2018
IW-Report 42/2018

(in cooperation with Anastasia Diel)
Gibt es einen Fachkräfteengpass in der deutschen Pharmaindustrie?
IW-Trends 3/2018

Die pharmazeutische Industrie in Deutschland – Ein Branchenportrait
4. Auflage des Branchenportraits

(in cooperation with Christian Rusche)
Versandhandel – Keine Bedrohung für den Apothekenmarkt
IW-Kurzbericht 15/2018

(in cooperation with Anastasia Diel)
Geringe Dynamik im Inlandsgeschäft
IW-Report 36/2017

Robuste Entwicklung trotz steigender Unsicherheit
IW-Kurzbericht 70/2017

Exportschlager Gesundheit – Wachstumstreiber Schwellenländer?
IW-Report 6/2017

Pharmaindustrie in Deutschland – Positive Entwicklung in 2015
IW-Report 15/2016

Musterpräsentation - Daten und Fakten der Pharmaindustrie
Pharmastandort Deutschland, 2016

Regionale Beschäftigungsstruktur wissensintensiver Industrien am Beispiel der Pharmabranche
IW-Trends 3/2014

Wissensbasis und regionale Agglomeration – Zwei Pharmacluster im Vergleich
IW-Trends 4/2012

(in cooperation with Jochen Pimpertz)
Gesundheitswesen – Wachstumsmotor mit Fragezeichen
Institut der deutschen Wirtschaft Köln (Hrsg.): Wirtschaftswachstum?! – Warum wir wachsen sollten und warum wir wachsen können, IW-Studien, Köln 2012, S. 131–147

Beschäftigungsstrukturen in hochinnovativen Branchen
IW-Trends 4/2010

Die forschenden Pharma-Unternehmen im Konjunkturverlauf
IW-Trends 1/2010

Expertises

(in cooperation with Anastasia Diel)
Daten und Fakten: Die deutsche Pharmaindustrie
Musterpräsentation im Auftrag des Verbands der forschenden Pharma-Unternehmen (vfa)

(in cooperation with Anastasia Diel)
Daten und Fakten der  Pharmaindustrie in Baden-Württemberg
Studie für den vfa, 2018

(in cooperation with Anastasia Diel)
Daten und Fakten der  Pharmaindustrie in Berlin
Studie für den vfa, 2018

(in cooperation with Anastasia Diel)
Daten und Fakten der  Pharmaindustrie in NRW
Studie für den vfa, 2018

(in cooperation with Anastasia Diel)
Daten und Fakten der  Pharmaindustrie in Hessen
Studie für den vfa, 2018

(in cooperation with Anastasia Diel)
Daten und Fakten der  Pharmaindustrie in Rheinland-Pfalz
Studie für den vfa, 2018

(in cooperation with Jochen Pimpertz)
Bewährtes schützt Vertraulichkeit und schafft Vertrauen
Forschungsstelle Pharmastandort Deutschland, Ordnungspolitisches Statement, 2016

Die pharmazeutische Industrie in Deutschland
Forschungsstelle Pharmastandort Deutschland, 3. Auflage des Branchenportraits, 2015

External Publications

Internationalization of Innovation Systems – Lessons from Eastern Europe
Kovac, Hamburg 2009, 395 Seiten (Euro-Wirtschaft: Studien zur ökonomischen Entwicklung Europas, 35), Zugl.: Univ., Diss., Bielefeld, 2009

The Applicability of the Concept of National Innovation Systems to Transition Economies
Innovation: Management, Policy & Practice, Issue 1, Vol. 9, 2007

National Innovation Systems in Transition Countries – The Impact of Institutional Organization and Change
Paper for the DRUID Tenth Anniversary Summer Conference, 2005

More from Dr. Jasmina Kirchhoff

Read study
Industry policy recommendations for a sustainable pharmaceutical industry
IW-Policy Paper No. 22 24. September 2021

More medicines "made in Germany" via international networking

Jasmina Kirchhoff

The Corona pandemic has put the German pharmaceutical industry more than ever in the focus of political and social discussions. At an unprecedented speed, pharmaceutical companies have developed and brought to market four vaccines approved in Europe – German companies have played a major role in this success.

IW

Read study
How Dependent Is the Industry on Foreign Sources?
IW-Trends No. 4 10. November 2020

Production Structures and Supply Chains in the German Pharmaceutical Sector

Michael Grömling / Jasmina Kirchhoff

The corona pandemic has reinforced earlier calls for national sovereignty over critical technologies, with policymakers, the business world and society as a whole focusing their attention particularly on the pharmaceutical industry.

IW

Read study
The Corona Innovation Race in Science
IW-Report No. 17 5. May 2020

The Corona Innovation Race in Science

Jasmina Kirchhoff / Armin Mertens / Marc Scheufen

This report is an analysis of the scientific publications on the fight against the corona pandemic and its significance for Germany as a pharmaceutical location.

IW

Read study
Is There a Shortage of Skilled Workers in the German Pharmaceutical Industry?
IW-Trends No. 3 25. October 2018

Is There a Shortage of Skilled Workers in the German Pharmaceutical Industry?

Anastasia Diel / Jasmina Kirchhoff

Due to its specific employment structure, the pharmaceutical industry is increasingly being affected by Germany’s widely attested labour shortage. Although in general companies in the sector are actually less affected by bottlenecks than other industries, this is no reason for complacency.

IW

Read study
The Regional Employment Structure of Knowledge-Intensive Industries as Exemplified by the Pharmaceutical Industry
IW-Trends No. 3 25. September 2014

The Regional Employment Structure of Knowledge-Intensive Industries as Exemplified by the Pharmaceutical Industry

Jasmina Kirchhoff

Research-intensive sectors such as pharmaceuticals are a favourite focus of regional policy thanks to their favourable growth prospects. Since, in Germany, the importance of the pharmaceutical industry for regional manufacturing centres and the range and levels of skills in the sector itself differ widely from region to region, it is particularly suitable for an analysis of how factors such as industrial structure and human capital influence the regional significance and skill structures of knowledge-intensive industries. The results of the study suggest that, when locating plants, pharmaceutical companies consider both the structure of local manufacturing and the local population’s level of education. However, other factors seem to be more important for the development of the regional employment structure.

IW

Read study
Knowledge Base and Regional Agglomeration
IW-Trends No. 4 25. December 2012

Knowledge Base and Regional Agglomeration

Jasmina Kirchhoff

A Comparison of Two Pharmaceutical Clusters

IW

Content element with id 8880 Content element with id 9713